4//SEC Filing
Malin Life Sciences Holdings Ltd 4
Accession 0001104659-21-144590
CIK 0001661460other
Filed
Nov 28, 7:00 PM ET
Accepted
Nov 29, 7:55 PM ET
Size
8.5 KB
Accession
0001104659-21-144590
Insider Transaction Report
Form 4
Malin Life Sciences Holdings Ltd
10% Owner
Transactions
- Purchase
COMMON STOCK
2021-11-26$6.81/sh+27,251$185,492→ 9,621,535 total - Purchase
COMMON STOCK
2021-11-24$6.89/sh+1,054$7,260→ 9,594,284 total - Purchase
COMMON STOCK
2021-11-29$6.89/sh+11,057$76,209→ 9,632,592 total
Footnotes (1)
- [F1]The reported prices in Column 4 are weighted average prices. Those shares were purchased in multiple transactions at per share prices ranging from $6.82 to $6.90 on 11/24/2021; $6.66 to $6.90 on 11/26/2021; and $6.86 to $6.90 on 11/29/2021. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
Poseida Therapeutics, Inc.
CIK 0001661460
Entity typeother
IncorporatedIreland
Related Parties
1- filerCIK 0001685138
Filing Metadata
- Form type
- 4
- Filed
- Nov 28, 7:00 PM ET
- Accepted
- Nov 29, 7:55 PM ET
- Size
- 8.5 KB